4basebio PLC (AIM:4BB)
London
· Delayed Price · Currency is GBP · Price in GBX 900.00
0.00 (0.00%)
Aug 15, 2025, 12:03 PM GMT+1
4basebio Revenue
In the year 2024, 4basebio had annual revenue of 933.00K GBP with 84.39% growth. 4basebio had revenue of 605.00K in the half year ending December 31, 2024, with 421.55% growth.
Revenue
933.00K
Revenue Growth
+84.39%
P/S Ratio
149.30
Revenue / Employee
8.48K
Employees
110
Market Cap
139.30M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| Oxford Nanopore Technologies | 183.19M |
| HUTCHMED (China) | 439.54M |